We welcome organizations, institutions, vendors and industry involvement.

Contact us to add your logo or to become a Partner or Patron.


2023 Lead Partner

CSID

CSID is a disorder that reduces the effectiveness of enzymes that digest carbohydrates (sugar and starch). Congenital Sucrase-Isomaltase Deficiency, also known as Genetic Sucrase-Isomaltase Deficiency (GSID), is an inherited disorder that causes these digestive enzymes either to be missing or to not work as well. Sucraid® is the only FDA-approved enzyme replacement therapy for the treatment of CSID.


2023 Fellow Partners


Friends of World IBS Day


Australia


Austria


Canada


Denmark


France


Germany


India


Ireland


Italy


Japan


Malaysia


Netherlands


Norway


Spain


United Kingdom


United States


Worldwide

World IBS Day is coordinated by the IBS Patient Support Group